AU2020901334A0 - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
AU2020901334A0
AU2020901334A0 AU2020901334A AU2020901334A AU2020901334A0 AU 2020901334 A0 AU2020901334 A0 AU 2020901334A0 AU 2020901334 A AU2020901334 A AU 2020901334A AU 2020901334 A AU2020901334 A AU 2020901334A AU 2020901334 A0 AU2020901334 A0 AU 2020901334A0
Authority
AU
Australia
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2020901334A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
QIMR Berghofer Medical Research Institute
Original Assignee
Queensland Institute of Medical Research QIMR
Filing date
Publication date
Application filed by Queensland Institute of Medical Research QIMR filed Critical Queensland Institute of Medical Research QIMR
Publication of AU2020901334A0 publication Critical patent/AU2020901334A0/en
Priority to US17/921,945 priority Critical patent/US20230173061A1/en
Priority to PCT/AU2021/050385 priority patent/WO2021217206A1/en
Priority to JP2022564217A priority patent/JP2023526766A/en
Priority to AU2021263337A priority patent/AU2021263337A1/en
Priority to BR112022021769A priority patent/BR112022021769A2/en
Priority to MX2022013490A priority patent/MX2022013490A/en
Priority to IL297736A priority patent/IL297736A/en
Priority to KR1020227040909A priority patent/KR20230005899A/en
Priority to EP21796930.2A priority patent/EP4143208A4/en
Priority to CA3177020A priority patent/CA3177020A1/en
Priority to CN202180045562.6A priority patent/CN117202929A/en
Pending legal-status Critical Current

Links

AU2020901334A 2020-04-28 2020-04-28 Pharmaceutical composition Pending AU2020901334A0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
CN202180045562.6A CN117202929A (en) 2020-04-28 2021-04-28 Human cytomegalovirus multi-epitope vaccine composition
BR112022021769A BR112022021769A2 (en) 2020-04-28 2021-04-28 HUMAN CYTOMEGALOVIRUS POLYEpitope VACCINE COMPOSITION
PCT/AU2021/050385 WO2021217206A1 (en) 2020-04-28 2021-04-28 Human cytomegalovirus polyepitope vaccine composition
JP2022564217A JP2023526766A (en) 2020-04-28 2021-04-28 Human cytomegalovirus polyepitope vaccine composition
AU2021263337A AU2021263337A1 (en) 2020-04-28 2021-04-28 Human cytomegalovirus polyepitope vaccine composition
US17/921,945 US20230173061A1 (en) 2020-04-28 2021-04-28 Human cytomegalovirus polyepitope vaccine composition
MX2022013490A MX2022013490A (en) 2020-04-28 2021-04-28 Human cytomegalovirus polyepitope vaccine composition.
IL297736A IL297736A (en) 2020-04-28 2021-04-28 Human cytomegalovirus polyepitope vaccine composition
KR1020227040909A KR20230005899A (en) 2020-04-28 2021-04-28 Human cytomegalovirus polyepitope vaccine composition
EP21796930.2A EP4143208A4 (en) 2020-04-28 2021-04-28 Human cytomegalovirus polyepitope vaccine composition
CA3177020A CA3177020A1 (en) 2020-04-28 2021-04-28 Human cytomegalovirus polyepitope vaccine composition

Publications (1)

Publication Number Publication Date
AU2020901334A0 true AU2020901334A0 (en) 2020-05-14

Family

ID=

Similar Documents

Publication Publication Date Title
GB202019241D0 (en) Pharmaceutical composition
EP4148096A4 (en) Composition
IL304290A (en) Pharmaceutical composition
EP4015001A4 (en) Oral pharmaceutical composition
EP3964264A4 (en) Novel pharmaceutical composition
EP3984549A4 (en) Medicinal composition
EP3949952A4 (en) Medicinal composition
EP3914234A4 (en) Pharmaceutical compositions
EP3950058A4 (en) Pharmaceutical composition having favorable stability
EP4005556A4 (en) Pharmaceutical composition comprising udenafil
EP3920909A4 (en) Pharmaceutical compositions comprising meloxicam
EP4129276A4 (en) Pharmaceutical composition
AU2020901334A0 (en) Pharmaceutical composition
AU2023901609A0 (en) Pharmaceutical composition
EP4176868A4 (en) Stable pharmaceutical composition
EP4032535A4 (en) Pharmaceutical composition
EP3991750A4 (en) Pharmaceutical composition
EP3957318A4 (en) Pharmaceutical composition
AU2020903781A0 (en) Pharmaceutical formulations
AU2020903780A0 (en) Pharmaceutical formulations
GB202208464D0 (en) Pharmaceutical composition
AU2022416581A1 (en) Composition
GB202109271D0 (en) Pharmaceutical composition
GB202108387D0 (en) Pharmaceutical composition
GB202107518D0 (en) Pharmaceutical composition